<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989053</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-09-GAR-078-CTIL</org_study_id>
    <nct_id>NCT00989053</nct_id>
  </id_info>
  <brief_title>The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)</brief_title>
  <official_title>The Effect of SSRI Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing In Vitro Fertilization for Unexplained Infertility - a Prospective Placebo-Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <brief_summary>
    <textblock>
      Women undergoing IVF show a high prevalence of depressive and anxiety symptoms. Furthermore,
      stress has harmful consequences on IVF and pregnancy outcomes. An immunological cascade was
      suggested to be involved in the process. Treatment in this setting is usually psychotherapy
      rather than pharmacotherapy, despite reasonable biological evidence suggesting beneficial
      influence of antidepressant therapy on pregnancy and well-being. Moreover, pharmacotherapy is
      more available and affordable than psychotherapy in the public health system. The
      investigators suggest to study the efficacy of antidepressant treatment in women undergoing
      IVF treatment, presenting with mild mood symptoms. The investigators hypothesize that
      treatment will result in a greater attenuation of affective symptoms, as well as in higher
      pregnancy success rates. Furthermore, certain immunological stress-reactive factors, may
      prove to be the biological mechanism underlying these effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>positive blood Î²HCG</measure>
    <time_frame>2 months from date of signing informed consent</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>psychiatric evaluation questionnaires</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>In Vitro Fertilization</condition>
  <arm_group>
    <arm_group_label>escitalopram</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>escitalopram</intervention_name>
    <description>10 mg/d for a duration of 8 weeks</description>
    <arm_group_label>escitalopram</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>1 pill per day for 8 weeks</description>
    <arm_group_label>escitalopram</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women 18 - 45 y.o.

          2. A score higher then 45 on the Zung Self-Rating Anxiety Scale or a score higher then 16
             on the Center for Epidemiologic Studies Depression Scale

          3. Understanding of Hebrew

          4. Willing to sign the informed consent

        Exclusion Criteria:

          1. An axis I DSM IVTR diagnosis other then a depressive, adjustment or anxiety disorder

          2. Suicidal ideation

          3. Current treatment with antidepressant medication

          4. Physical illness explaining depressive symptoms (e.g. hypothyroidism, neurological
             disease, severe anemia, renal failure etc.)

          5. Alcoholism or drug abuse and dependence

          6. Past severe side effects to SSRIs

          7. Failed IVF (4 trials of good quality embryo reinstatement without achieving pregnancy)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gabi Aisenberg Romano, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2009</study_first_submitted>
  <study_first_submitted_qc>October 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2009</study_first_posted>
  <last_update_submitted>October 1, 2009</last_update_submitted>
  <last_update_submitted_qc>October 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>dr.Gabi Aisenberg Romano M.D</name_title>
    <organization>Tel aviv Sourasky medical center</organization>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>anxiety</keyword>
  <keyword>stress</keyword>
  <keyword>antidepressant therapy</keyword>
  <keyword>SSRI</keyword>
  <keyword>infertility</keyword>
  <keyword>in vitro fertilization (IVF)</keyword>
  <keyword>immunological factors</keyword>
  <keyword>depressive and anxiety symptoms in women undergoing IVF treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Affective Symptoms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Serotonin Uptake Inhibitors</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

